Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

1 - 20  of 48115 results

Filter or search again

Sort by:  Latest first

  • Expensive night out

    The Pharmaceutical Journal, 20 September 2014, Vol 293, No 7828

    Charging a fee for being drunk in A&E would do little to improve people’s attitudes to alcohol.

  • Profession must adapt in a fast-paced environment

    19 SEP 2014

    In order to meet the evolving needs of patients, the pharmaceutical profession needs to evolve too.

  • How to increase the accessibility of pharmacists when the pharmacy is open

    19 SEP 2014

    There are ways to make community pharmacists more accessible to meet patient demand.

  • Is it imperative to change the image and self-concept of pharmacists?

    19 SEP 2014

    The image of pharmacists needs to be changed so that patients view them as clinical practitioners.

  • New melanoma treatment approved by NICE

    19 SEP 2014

    The National Institute for Health and care Excellence has issued draft guidance recommending that dabrafenib should be available on the NHS for the treatment of melanoma that has spread or can’t be completely removed by surgery in patients with a BRAF gene mutation.

  • How do future pharmacists view themselves and the profession?

    19 SEP 2014

    Tomorrow’s pharmacists need to have a positive self-image and view of the profession, but there are challenges to overcome.

  • Membership to the Royal Pharmaceutical Society

    19 SEP 2014

    If you are a Royal Pharmaceutical Society fellow, member, associate member or pharmaceutical scientist member, you will have full access to pharmaceutical-journal.com and full subscription to the print edition of The Pharmaceutical Journal.  Categories Practising pharmacists in GB Non-GB pharmacists Pharmacy ...

  • Pharmacy regulator wants to overturn Scottish judgement

    19 SEP 2014

    The General Pharmaceutical Council is appealing against the decision by three senior Scottish judges to overturn a fitness to practice ruling, will go to the Supreme Court in order to clarify its disciplinary options.

  • The geographical distribution of pharmacies affects accessibility

    19 SEP 2014

    Community pharmacies are more than just bricks and mortar, they are the social fabric in communities.

  • Pharmacists are advised to store Buscopan and baclofen separately to avoid errors

    19 SEP 2014

    Several occurrences of patients being given the wrong medicine has led to a recommendation that Buscopan (hyoscine butylbromide) and baclofen be stored separately.

  • The supply of medicines is no longer enough to community pharmacy

    19 SEP 2014

    Patients and governments need to be sure the services pharmacy provides are value for money.

  • Evidence base does not always work in retail environment

    19 SEP 2014

    I read with interest Anthony Cox’s piece on evidence-based medicine (EBM) in over-the-counter (OTC) products (The Pharmaceutical Journal 2014;293:176). As a community pharmacist with a strong support for EBM, I enjoyed the enthusiasm and desire to strive for this approach with OTC products. However, I found his piece offensive to community pharmacists implying what ...

  • Pick the perfect painkiller

    19 SEP 2014

    13 September 2014: The Daily Mail featured an article called ‘Pick the perfect painkiller’. It looked at paracetamol, ibuprofen, pain-relieving gels and other products. Speaking about paracetamol and the benefits of it for muscular pain such as sprains, strains and ligament pain, Royal Pharmaceutical Society spokesman Sid Dajani said: “Many people — particularly men — believe ibuprofen is more powerful, but there’s no evidence to support this, and paracetamol is much kinder ...

  • Pharmacy staff flu vaccination

    19 SEP 2014

    The Department for Health has written a letter to the Pharmaceutical Services Negotiating Committee urging all pharmacy staff to be vaccinated against the influenza virus this season, which is recommended by the Joint Committee on Vaccination and Immunisation. The secretary of state for health set a target of 75% of healthcare workers to be vaccinated. It ...

  • Fostair NEXThaler launched

    19 SEP 2014

    The Fostair NEXThaler (beclometasone dipropionate and formoterol fumarate) 100micrograms/6micrograms is being launched in the UK by Chiesi on 22 September 2014. Net price one inhaler, 120 actuations, £29.32.

  • Gynest discontinuation

    19 SEP 2014

    Gynest cream (estriol) 0.01% with applicator, 80g pack, is being discontinued by Marlborough Pharmaceuticals. A generic version of the product is available from Sovereign Medical. Further information on 01268 594774.

  • Eviplera shelf life extended

    19 SEP 2014

    The shelf life of Eviplera (emtricitabine/rilpivirine/tenofovir disoproxil) has been extended from 2 to 3 years in the summary of product characteristics.

  • Freedom to Speak Up survey calls on pharmacists

    19 SEP 2014

    All registered pharmacy professionals working in GP surgeries or community pharmacies in England are invited to take part in a survey as part of Sir Robert Francis’ independent review called Freedom to Speak Up. Pharmacists are asked to anonymously ...

  • Guidelines in practice free webinars

    19 SEP 2014

    Guidelines in Practice, a monthly journal which promotes best practice in healthcare, is hosting three free webinars which can be watched live or on demand. The first is on lipid modification, the second on atrial fibrillation and the third on...

  • NICE recommends dabrafenib in final draft guidance

    19 SEP 2014

    The National Institute for Health and Care Excellence has issued final draft guidance for consultation recommending the new skin cancer drug, dabrafenib. Appeals against the decision can be lodged until 2 October 2014.

View results  10 per page   20 per page   50 per page  

Filter Your Search